This article introduces the utilizing of ferrocene as a non-classical moiety for the construction of drug molecules. The research results from ITRI’s Drug R&D Team and literatures demonstrated these ferrocene derivatives possess acceptable biological activities. However, in order to move forward these ferrocene moiety containing molecules into drug candidates, more researches have to be done to improve their druggable properties.